Skip to main content

3 Reasons to Avoid EXPO and 1 Stock to Buy Instead

EXPO Cover Image

Since September 2025, Exponent has been in a holding pattern, posting a small loss of 1% while floating around $70.25.

Is there a buying opportunity in Exponent, or does it present a risk to your portfolio? See what our analysts have to say in our full research report, it’s free.

Why Is Exponent Not Exciting?

We're swiping left on Exponent for now. Here are three reasons why EXPO doesn't excite us and a stock we'd rather own.

1. Lackluster Revenue Growth

We at StockStory place the most emphasis on long-term growth, but within business services, a stretched historical view may miss recent innovations or disruptive industry trends. Exponent’s recent performance shows its demand has slowed as its annualized revenue growth of 3.9% over the last two years was below its five-year trend. We’re wary when companies in the sector see decelerations in revenue growth, as it could signal changing consumer tastes aided by low switching costs. Exponent Year-On-Year Revenue Growth

2. Free Cash Flow Margin Dropping

If you’ve followed StockStory for a while, you know we emphasize free cash flow. Why, you ask? We believe that in the end, cash is king, and you can’t use accounting profits to pay the bills.

As you can see below, Exponent’s margin dropped by 4.3 percentage points over the last five years. If its declines continue, it could signal increasing investment needs and capital intensity. Exponent’s free cash flow margin for the trailing 12 months was 22.8%.

Exponent Trailing 12-Month Free Cash Flow Margin

3. New Investments Fail to Bear Fruit as ROIC Declines

We like to invest in businesses with high returns, but the trend in a company’s ROIC can also be an early indicator of future business quality.

We like to invest in businesses with high returns, but the trend in a company’s ROIC is what often surprises the market and moves the stock price. Over the last few years, Exponent’s ROIC has unfortunately decreased significantly. We like what management has done in the past, but its declining returns are perhaps a symptom of fewer profitable growth opportunities.

Exponent Trailing 12-Month Return On Invested Capital

Final Judgment

Exponent isn’t a terrible business, but it isn’t one of our picks. That said, the stock currently trades at 31.8× forward P/E (or $70.25 per share). This multiple tells us a lot of good news is priced in - we think other companies feature superior fundamentals at the moment. We’d recommend looking at a safe-and-steady industrials business benefiting from an upgrade cycle.

Stocks We Like More Than Exponent

ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.

Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  209.53
+0.00 (0.00%)
AAPL  255.76
+0.00 (0.00%)
AMD  197.74
+0.00 (0.00%)
BAC  47.13
+0.00 (0.00%)
GOOG  303.21
+0.00 (0.00%)
META  638.18
+0.00 (0.00%)
MSFT  401.86
+0.00 (0.00%)
NVDA  183.14
+0.00 (0.00%)
ORCL  159.16
+0.00 (0.00%)
TSLA  395.01
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.